Asset Details
Do you wish to reserve the book?
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review
Do you wish to request the book?
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Efficacy of phage therapy in controlling staphylococcal biofilms: a systematic review
2025
Overview
Background
Antibiotic-resistant bacteria pose an urgent health threat as mutations have led to resistant strains that evade treatment. These bacteria form biofilms, complicating infection management. Bacteriophages are being recognized for their potential in phage therapy due to their effectiveness in rapidly targeting and eliminating bacterial hosts.
Materials and methods
This systematic review examined the effectiveness of bacteriophages against biofilms created by antibiotic- and drug-resistant staphylococcal strains. A thorough search of the Embase, Web of Science, PubMed, and Scopus databases was conducted for studies published from 2012 to October 29, 2024, focusing on relevant research while excluding irrelevant studies.
Results
This systematic review assesses the effectiveness of phage-derived enzymes, including endolysins and depolymerases, as well as whole bacteriophages, in degrading biofilms and clearing bacteria. It also highlights how combining phages with antibiotics or other agents can improve biofilm removal. The review explores the potential applications of phage therapy in various contexts, such as infections related to milk, silicone surfaces, synovial fluid, and prosthetic joint materials. Overall, while phage therapy shows promise as an alternative to antibiotics, additional research is necessary to refine treatment methods and ensure safety.
Conclusions
Bacteriophages hold potential as a standalone treatment and a complementary option to traditional antibiotics for managing
S. aureus
biofilms, but further research is needed to understand their clinical potential. Additional studies on phage selection, dosing, and administration methods are necessary, along with exploration of phage–antibiotic synergy mechanisms and assessment of the safety and environmental impacts of phage therapy.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
Anti-Bacterial Agents - pharmacology
/ Anti-Bacterial Agents - therapeutic use
/ Bacteria
/ Biofilms
/ Biofilms - growth & development
/ Drug resistance in microorganisms
/ Enzymes
/ Humans
/ Lysins
/ Medicine
/ Oncology
/ Review
/ Staphylococcal Infections - microbiology
/ Staphylococcal Infections - therapy
/ Staphylococcus aureus - physiology
/ Staphylococcus aureus - virology
/ Surgery
